|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
TRALOKINUMAB |
D11AH07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005255 |
17-06-2021 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
REMIMAZOLAM |
N05CD14 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005246 |
26-03-2021 |
VALID
|
|
TIRATRICOL |
H03AA04 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/005220 |
12-02-2025 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
BUPIVACAINE AND MELOXICAM |
N01BB59 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005205 |
24-09-2020 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
FINERENONE |
C03DA05 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005169 |
18-11-2020 |
VALID
|
|
PRETOMANID |
J04AK08 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005167 |
31-07-2020 |
VALID
|
|
PONESIMOD |
L04AE04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
FILGOTINIB |
L04AF04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
LEFAMULIN |
J01XX12 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005048 |
27-07-2020 |
VALID
|
|
LUMASIRAN |
A16AX18 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
SOMAPACITAN |
H01AC07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005030 |
31-03-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
ULIPRISTAL |
G03XB02 |
FR
|
I
|
12-11-2018 |
EMEA/H/C/005017 |
09-02-2018 |
VALID
|
|
FOSTAMATINIB |
B02BX09 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/005012 |
09-01-2020 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
ISATUXIMAB |
L01FC02 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004977 |
30-05-2020 |
VALID
|
|
CABOTEGRAVIR |
J05AJ04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004976 |
17-12-2020 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
IBALIZUMAB |
J05AX23 |
FR
|
I
|
27-11-2019 |
EMEA/H/C/004961 |
25-09-2019 |
VALID
|
|
BEMPEDOIC ACID AND EZETIMIBE |
C10BA10 |
FR
|
I
|
10-12-2024 |
EMEA/H/C/004959 |
27-03-2020 |
VALID
|
|
BEMPEDOIC ACID |
C10AX15 |
FR
|
I
|
09-12-2024 |
EMEA/H/C/004958 |
01-04-2020 |
VALID
|
|
RAVULIZUMAB |
L04AJ02 |
FR
|
I
|
27-11-2019 |
EMEA/H/C/004954 |
01-07-2019 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
BROLUCIZUMAB |
S01LA06 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004913 |
13-02-2020 |
VALID
|
|
METFORMIN, SAXAGLIPTIN AND DAPAGLIFLOZIN |
A10BD25 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004910 |
11-11-2019 |
VALID
|
|
LAMIVUDINE AND DOLUTEGRAVIR |
J05AR25 |
FR
|
I
|
|
EMEA/H/C/004909 |
30-06-2019 |
VALID
|
|
SOLRIAMFETOL |
N06BA14 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004893 |
16-01-2020 |
VALID
|
|
GLASDEGIB |
L01XX63 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004878 |
26-06-2020 |
VALID
|
|
CRIZANLIZUMAB |
B06AX01 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004874 |
28-10-2020 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004870 |
16-01-2020 |
VALID
|
|
VOXELOTOR |
B06AX03 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
CRISABOROLE |
D11AH06 |
FR
|
II
|
03-03-2021 |
EMEA/H/C/004863 |
27-03-2020 |
VALID
|